Assessing the Attainment Rates of Updated CDC Milestones Using a New Israeli Developmental Scale.


Journal

Pediatrics
ISSN: 1098-4275
Titre abrégé: Pediatrics
Pays: United States
ID NLM: 0376422

Informations de publication

Date de publication:
01 12 2022
Historique:
accepted: 19 09 2022
pubmed: 19 11 2022
medline: 3 12 2022
entrez: 18 11 2022
Statut: ppublish

Résumé

Developmental milestones norms are widely used worldwide and are fundamental for early childhood developmental surveillance. We compared a new Israeli evidence-based national developmental scale with the recently updated Centers for Disease Control and Prevention (CDC) checklists. We used a cohort of nearly 4.5 million developmental assessments of 758 300 full-term born children aged 0 to 6 years (ALL-FT cohort), who visited maternal child health clinics in Israel for routine developmental surveillance. Among the assessed milestones of 4 developmental domains (gross motor, fine motor, language, and personal-social) we identified milestones that had equivalents on the CDC checklists and assessed the attainment rates of the Israeli children at the ages recommended by the CDC, at which ≥75% of the children would be expected to achieve the milestone. The analysis was repeated on a subgroup of 658 958 children who were considered healthy, typically developing by their birth and growth characteristics (NORMAL-FT cohort). There were 29 milestones, across all developmental domains and assessment ages, whose definitions by both tools were compatible, and could be compared. The attainment rate at the CDC-recommended age was >90% for 22 (76%) and 23 (79%) milestones, and the median attainment rates were 95.2% and 96.3% in the ALL-FT and NORMAL-FT cohorts, respectively. For almost all comparable milestones of all domains and all ages, children of the Israeli cohorts achieved the milestones earlier than expected by the CDC-defined threshold age. Evidence-based analysis of milestone norms among different populations may enable adjustments of developmental scales and facilitate more personalized developmental surveillance.

Identifiants

pubmed: 36398448
pii: 190079
doi: 10.1542/peds.2022-057499
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2022 by the American Academy of Pediatrics.

Auteurs

Yair Sadaka (Y)

Neuro-Developmental Research Center, Mental Health Institute, Be'er Sheva, Israel.
KI Research Institute, Kfar Malal, Israel.
Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er-Sheva, Israel.

Tamar Sudry (T)

Neuro-Developmental Research Center, Mental Health Institute, Be'er Sheva, Israel.
KI Research Institute, Kfar Malal, Israel.

Deena R Zimmerman (DR)

Public Health Services.

Meytal Avgil Tsadok (M)

TIMNA Initiative, Big Data Platform.

Ravit Baruch (R)

Public Health Services.

Hadar Yardeni (H)

Department of Child Development and Rehabilitation, Israel Ministry of Health, Jerusalem, Israel.

Dror Ben Moshe (D)

TIMNA Initiative, Big Data Platform.

Pinchas Akiva (P)

KI Research Institute, Kfar Malal, Israel.

Guy Amit (G)

KI Research Institute, Kfar Malal, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH